FDA Drug Application (202012) for EPROSARTAN MESYLATE by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number202012
Product Number001
FormTABLET;ORAL
DosageEQ 400MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameEPROSARTAN MESYLATE
Active IngredientEPROSARTAN MESYLATE

Active IngredientCount
List of drugs with Active Ingredient EPROSARTAN MESYLATE3


Back to FDA Applications sponsored by MYLAN PHARMS INC